ロード中...
Hypoglycaemic effects of the novel antidiabetic agent repaglinide in rats and dogs
1. Repaglinide, a novel compound with a nonsulphonylurea structure, is currently being clinically tested as a therapeutic agent. In the present study, the hypoglycaemic effects of repaglinide in rats and dogs were investigated. 2. Whereas the R-enantiomer, AG-EE 624 ZW, showed only weak hypoglycaemi...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1997
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1564864/ https://ncbi.nlm.nih.gov/pubmed/9283692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0701307 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|